Jaihind Industries has cleared a major capital raise of Rs 99.32 crore through the issuance of 2.36 crore convertible warrants at Rs 42 each. The company also announced a leadership change, appointing Mr. Prasham Kumar Doshi as Managing Director for a five-year term, and plans to increase its authorised share capital to Rs 30 crore to support future growth, particularly in its healthcare and hospital business.
Jaihind Industries Sets Expansion Path With Rs 99 Crore Fundraise
Jaihind Industries has approved a preferential issue of 2.36 crore warrants at Rs 42 per warrant, totalling Rs 99.32 crore.
The company is increasing its authorised share capital from Rs 9 crore to Rs 30 crore to facilitate long-term growth.
Reader Takeaway: The company is aggressively pivoting toward healthcare expansion, though the 18-month warrant conversion window warrants monitoring.
What just happened
At its 39th Annual General Meeting held on October 11, 2026, Jaihind Industries secured shareholder approval for a significant capital infusion. The firm will issue over 2.36 crore warrants, with 25% of the capital payable upfront. Each warrant grants the right to subscribe to one equity share within an 18-month period. Additionally, the company has formally appointed Mr. Prasham Kumar Doshi as Managing Director for a five-year tenure beginning August 2026.
Why this matters
The capital raise marks a strategic shift in the company's business model. A substantial Rs 65 crore—over 65% of the total proceeds—is earmarked for the healthcare and hospital business. Another Rs 20 crore is allocated to textiles and trading, with the remainder supporting working capital and general corporate needs. The increase in authorised share capital to Rs 30 crore signals that the board is preparing the company's balance sheet for further potential equity activity.
Management and Governance
The transition in leadership is a critical watch point. Mr. Prasham Kumar Doshi takes over the helm during a phase of capital expansion. Investors should observe if this leadership change aligns with the successful execution of the proposed hospital projects.
What to track next
Watch for the official allotment of these warrants and the subsequent quarterly filings detailing the actual deployment of funds into the healthcare segment. The market will also be assessing whether the newly appointed management can drive efficiency in the firm's core operational areas while integrating new hospital-focused investments.